Siemens Healthineers upgrades mid-term guidance
Germany-based Siemens Healthineers is now expecting revenue growth of 6-8 percent in the period 2023-2025, up from its prior 5-percent estimate. Morever, the projection for earnings per share in this period is also raised, going from 10 percent to 15 percent.
by marketwire, translated by daniel pedersen
Siemens Healthineers, which sells products and solutions for the prevention, diagnosing, treatment and monitoring of diseases, has upgraded its mid-term guidance, Bloomberg News reports ahead of the company's capital markets day, referring to a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Amcham welcomes new chairwoman from Siemens Healthineers
For subscribers
GE to capitalize on increasing demand for diagnostics
For subscribers
